10-QPeriod: Q2 FY2016

SYNOPSYS INC Quarterly Report for Q2 Ended Apr 30, 2016

Filed May 24, 2016For Securities:SNPS

Summary

Synopsys Inc. reported solid financial results for the quarter and six months ended April 30, 2016, demonstrating continued revenue growth and profitability. Total revenue increased by 9% year-over-year for the quarter and 7% for the six-month period, primarily driven by an increase in time-based license revenue, which continues to represent the majority of the company's revenue. The company's strong operational performance is supported by its robust time-based revenue model, which provides a predictable revenue stream. Synopsys also maintained a healthy cash position, with cash, cash equivalents, and short-term investments totaling $959.9 million. The company continued to execute on its strategic objectives, including investments in research and development and acquisitions, while also actively managing its capital through stock repurchases.

Financial Highlights

53 data points
Beta

Revenue

$605.00M

78.2% Gross Margin

Net Income

$69.38M

11.5% Net Margin

EPS (Diluted)

$0.45

Total Assets

$4.97B

Cash & Equivalents

$827.95M

Free Cash Flow

$208.87M

Financial Statements
Beta
Revenue$605.00M
Cost of Revenue$131.63M
Gross Profit$473.38M
R&D Expenses$216.17M
Operating Expenses$386.57M
Operating Income$86.81M
Interest Expense$848K
Net Income$69.38M
EPS (Basic)$0.46
EPS (Diluted)$0.45
Shares Outstanding (Basic)152.25M
Shares Outstanding (Diluted)154.54M

Key Highlights

  • 1Total revenue increased by 9% to $605.0 million for the three months ended April 30, 2016, compared to $557.2 million in the prior year period.
  • 2Time-based license revenue, the company's primary revenue stream, grew 8% to $484.2 million for the quarter.
  • 3Gross margin remained strong at 78% for the quarter, indicating effective cost management.
  • 4Research and development expenses increased by 15% to $216.2 million, reflecting continued investment in innovation.
  • 5Net income increased by 25% to $69.4 million for the quarter, showcasing improved profitability.
  • 6The company maintained a healthy liquidity position with $959.9 million in cash, cash equivalents, and short-term investments as of April 30, 2016.
  • 7Synopsys repurchased approximately $20.0 million of its common stock during the quarter.

Frequently Asked Questions

Synopsys' primary revenue driver is its time-based license revenue, which accounted for approximately 80% of total revenue in the quarter ended April 30, 2016. This segment showed a healthy increase of 8% year-over-year, indicating sustained demand for its core offerings and the stability provided by its subscription-based revenue model.

Synopsys continues to invest in future growth, with Research and Development expenses increasing by 15% year-over-year. Sales and Marketing expenses remained relatively flat for the quarter, suggesting efficient management of go-to-market strategies, though they saw an increase of 7% for the six-month period due to headcount and variable compensation adjustments.

As of April 30, 2016, Synopsys maintained a strong liquidity position with $959.9 million in cash, cash equivalents, and short-term investments. The company is utilizing its cash for strategic investments in R&D, acquisitions, and significant stock repurchase programs, demonstrating a commitment to returning value to shareholders while investing in future growth.

Synopsys is involved in ongoing patent litigation with Mentor Graphics Corporation. While recent rulings have been mixed, with some in favor of Synopsys and others leading to damage assessments and injunctions, the company is appealing certain decisions. Investors should monitor the outcomes of these appeals as they could potentially impact future sales or incur significant legal costs.